Premium
Evaluation of the modified Glasgow Prognostic Score to predict outcome in dogs with newly diagnosed lymphoma
Author(s) -
Fontaine S. J.,
McCulloch E.,
Eckersall P. D.,
Haining H.,
Patterson Kane J. C.,
Morris J. S.
Publication year - 2017
Publication title -
veterinary and comparative oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.864
H-Index - 34
eISSN - 1476-5829
pISSN - 1476-5810
DOI - 10.1111/vco.12296
Subject(s) - lethargy , canine lymphoma , medicine , lymphoma , univariate analysis , c reactive protein , gastroenterology , multivariate analysis , stage (stratigraphy) , univariate , albumin , inflammation , multivariate statistics , biology , paleontology , statistics , mathematics
The modified Glasgow Prognostic Score ( mGPS ) assigns a numerical value (0–2) from pre‐treatment serum concentrations of C‐reactive protein ( CRP ) and albumin to predict patient outcome. CRP and albumin were evaluated in 77 untreated dogs with lymphoma to determine the relationship of mGPS to clinicopathological parameters and whether it could predict progression‐free ( PFS ) and overall survival ( OS ) in treated dogs. mGPS distribution was significantly associated with clinical stage, substage b, weight loss, gastrointestinal disturbances and lethargy at presentation. On univariate analysis, mGPS was significantly associated with OS and PFS , with shorter median survival times for mGPS 2 compared to mGPS 0 and 1 combined. Hypoalbuminaemia significantly reduced OS and PFS , however increased CRP had no effect. Only clinical stage was significantly associated with OS and PFS on both univariate and multivariate analysis. mGPS has potential prognostic value for canine lymphoma , but further studies are needed.